Highlights
- •Both high and low HbA1c were associated with higher mortality in elderly diabetics.
- •A 3-fold increase in odd ratio for mortality was noted when the HbA1c was <6.0%.
- •Risk factors for mortality included smoking, low BMI, high LDL, and sulphonylureas.
- •Aggressive glycaemic control should be approached cautiously in the elderly.
Abstract
Objective
To examine the association between the most recent HbA1c values and the mortality
of elderly Type 2 Diabetic (T2DM) patients managed in the public primary care setting
and to explore the associating risk factors.
Design
Retrospective cohort study.
Subjects
All T2DM patients aged 65 or above, who attended a public primary care clinic for
regular follow up from 01/01/2012 to 31/12/2012 were included. Their follow up status
till 31/12/2017 was reviewed. Those who were deceased on or before 31/12/2017 were
matched randomly with controls that were alive in the same cohort for comparison.
Main Outcome Measures
Patients’ demographics, smoking status, duration of T2DM, biochemical parameters including
the most recent HbA1c, lipid profile, renal function test, drug profile, co-morbidities
and all-cause mortality were retrieved from Hospital Authority’s CDARS and CMS systems.
Results
Both high (>8.0%) and low (<6.5%) HbA1c values were associated with increased odd
ratio of all-cause mortality among T2DM elderly patients treated in the primary care.
There was a 3-fold increase in odd ratio when the HbA1c reading was very low (<6.0%).
Associated risk factors for all-cause mortality in elderly T2DM patients included
smoker status, lower BMIs, and higher LDL levels and use of sulphonylureas.
Conclusions
Glycemic target for elderly T2DM patients should be approached cautiously. Over-aggressive
treatment may lead to increased mortality among elderly T2DM patients.
Keywords
To read this article in full you will need to make a payment
Subscribe to Primary Care Diabetes
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure.Arch. Intern. Med. 2008; 168: 1699
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.Bmj. 2000; 321: 405-412
- 10-year follow-up of intensive glucose control in type 2 diabetes.N. Engl. J. Med. 2008; 359: 1577-1589
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.N. Engl. J. Med. 2008; 358: 2560-2572
- Effects of Intensive Glucose Lowering in Type 2 Diabetes.N. Engl. J. Med. 2008; 358: 2545-2559
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.Bmj. 2010; (August; 340 (jan08 1))
- Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study.Lancet. 2010; 375: 481-489
- Effect of a multifactorial intervention on mortality in type 2 diabetes.N. Engl. J. Med. 2008; 358: 580-591
Resource Corner [Internet]. Diabetes-friendly Recipes | Resource Corner | Primary Care Office. Available from: https://www.pco.gov.hk/english/resource/professionals_diabetes_pdf.html.
- 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2018.Philos. Trans. R. Soc. B: Bio. Sci. 2018; (The Royal Society [Internet])
- Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary.Endocr. Pract. 2018; 24: 91-120
- Proposed Working Definition of an Older Person in Africa for the MDS Project.World Health Organization, 2016 (Available from: https://www.who.int/healthinfo/survey/ageingdefnolder/en/ [Internet])
RESEARCH RANDOMIZER [Internet]. Pair of dice. Available from: https://www.randomizer.org/.
Calculate confidence limits for a sample proportion. Available from: http://epitools.ausvet.com.au/content.php?page=SampleSize.
- Recent HbA1c values and mortality risk in type 2 diabetes. Population-based case-control study.PLoS One. 2013; 8
- Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.Diabetologia. 2006; 49: 930-936
- Effect of Aging on A1C Levels in Individuals Without Diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004.Diabetes Care. 2008; 31: 1991-1996
- Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes.Circ.: Cardiovasc. Qual. Outcomes. 2010; 3: 661-667
- Hemoglobin A1c predicts healing rate in diabetic wounds.J. Invest. Dermatol. 2011; 131: 2121-2127
- Smoking and diabetes—the double health hazard!.Prim. Care Diabetes. 2009; 3: 205-209
- Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site Cancer: the Hong Kong diabetes registry.Diabetes Care. 2014; 37: 1024-1031
- Body mass index and mortality in elderly men and women: the Tromsø and HUNT studies.J. Epidemiol. Community Health. 2011; 66: 611-617
- Association between body mass index and mortality in the Korean elderly: a nationwide cohort study.PLoS One. 2018; 13
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis.Lancet. 2008; 371: 117-125
- Infections in patients with diabetes mellitus.N. Engl. J. Med. 1999; 341: 1906-1912
- Diabetes mellitus, fasting glucose, and risk of cause-specific death.N. Engl. J. Med. 2011; 364: 829-841
- Associations of HbA1cand educational level with risk of cardiovascular events in 32 871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.Diabetic Med. 2013; 30
Article Info
Publication History
Published online: April 12, 2020
Accepted:
February 29,
2020
Received in revised form:
February 23,
2020
Received:
October 29,
2019
Identification
Copyright
© 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
